Hospital Acquired Pneumonia Prevention Market 2022
Hospital Acquired Pneumonia Prevention Market 2022
The global nosocomial pneumonia prevention market is expected to grow at a CAGR of 4.7% over the next decade. It is expected to reach US$1,100 million by 2026. With digitized communication channels moving towards the healthcare vertical, advanced clinics are in virtual consultation mode, and this scenario is expected to continue even in the future. Regulatory approvals for this type of communication are pending. Nearly 70% of public hospitals worldwide are urged to adopt digital means. This would be the scene with vertical health in the following period.
Get a free sample copy of this report @ https://www.persistencemarketresearch.com/samples/22768
Over an assessment period of eight years 2018-2026, the global nosocomial pneumonia prevention market is expected to witness moderate growth, according to a recent research report on the global nosocomial pneumonia prevention market. The report was published by Persistence Market Research and is titled “Hospital-Associated Pneumonia Prevention Market: Global Industry Analysis 2013-2017 and Forecast 2018-2026”. The US$795 million market is expected to grow at a CAGR of 4.7%, reaching a value of over US$1,100 million by the end of 2026.
Sage Products LLC (Stryker Corporation)
Medline Industries, Inc.
Halyard Health, Inc.
Methodology [email protected] https://www.persistencemarketresearch.com/methodology/22768
Key Market Drivers: Overview
Immunosenescence will remain a key driver of demand for nosocomial pneumonia prevention worldwide. The expansion of the geriatric population and consequent cessation of immunity is expected to maintain the need to regulate hospital-acquired pneumonia infection. Rising cases of chronic diseases leading to progressive weakening of the immune system also marks another powerful driver for market growth over the next few years.
The cessation of immunity in turn prolongs patients’ stay in hospitals, making them more susceptible to infections such as pneumonia. The global nosocomial pneumonia prevention market is expected to benefit from a continued surge of such cases, including people of all age groups.
Amplification of the patient pool across the globe coupled with an increasing number of hospitals in both developed and developing economies is expected to drive up the market scenario in the near future. Additionally, several countries are mandating the implementation of pneumonia prevention protocols, which is apprehended to create multiple growth opportunities in the coming years.
The market growth in developing economies will be specifically accelerated by the soaring burden of pneumonia cases in Southeast Asian countries. The medical tourism industry is thriving in emerging countries such as India is expected to fuel nosocomial pneumonia cases and hence increase the demand for its prevention in the coming years.
By Product Type, the market has been segmented into:
Oral Care Kit
By end-user, the market is classified as:
Home care settings
Access the full [email protected] https://www.persistencemarketresearch.com/checkout/22768
Regional Analysis: Overview
Regional segmentation of Global Nosocomial Pneumonia Prevention categorizes the market into North America, Latin America, Europe, Asia-Pacific excluding China, China, Middle East & Africa. Among these, North America will remain dominant in all other regional markets, mainly due to a favorable initiative by the US government to encourage innovation in the field of antibacterial drugs.
This government activity aims to respond to the urgent demand for better preventive measures against bacterial infections. Additionally, the demand for high-quality oral care products in hospital intensive care departments has increased due to the increase in cases of chronic kidney disease since the recent past. Europe occupies the second position in terms of market size, APEC is expected to be the third largest lucrative region; while China is expected to be the most promising emerging market with the highest estimated CAGR value of around 5.5%.
Key Market Players: Overview
Major companies operating in the global nosocomial pneumonia prevention market include Halyard Health, Inc., Sage Products LLC, Intersurgical Ltd., Medline Industries, Inc. and others. Attributed to the strong presence of a majority of key players such as Halyard Health, Inc., Medline Industries, Inc. and Stryker Corporation (SAGE Products LLC) in the United States, it has played a crucial role in improving the performance of the North American market for products acquired in the hospital setting. prevention of pneumonia over the years. As the number of specialized companies in the industry is limited, the overall scenario will remain price sensitive over the next few years.
Access related reports-
Medical and Industrial Gloves Market – https://www.persistencemarketresearch.com/market-research/medical-and-industrial-gloves-market.asp
Medical and industrial gloves market to reach $12,868.6 million by the end of 2026, showing robust expansion at a CAGR of 7.9% over the period 2018-2026.
Rehabilitation Equipment Market – https://www.persistencemarketresearch.com/market-research/rehabilitation-equipment-market.asp
The global rehabilitation equipment market is expected to reach a figure of approximately US$ 13,400 million in 2022 and is expected to exhibit a robust CAGR during the assessment period.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York, NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – [email protected]
PersistenceMarketResearch is a reputable company with a reputation for serving clients in the information technology (IT), healthcare and chemical industries. Our analysts undertake careful primary and secondary research to deliver a transparent report with a 360 degree perspective. Data is compared against reputable organizations, reliable databases and international surveys to produce impeccable reports supported by graphical and statistical information.
This press release was published on openPR.